SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-24-004451
Filing Date
2024-06-24
Accepted
2024-06-24 16:51:28
Documents
2

Document Format Files

Seq Description Document Type Size
1 UROGEN PHARMA LTD. p24-2248sc13g.htm SC 13G 67973
2 JOINT FILING AGREEMENT PURSUANT TO RULE 13D-1(K) p24-2248exhibit99.htm EX-99 5592
  Complete submission text file 0000902664-24-004451.txt   75076
Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

IRS No.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Subject) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89992 | Film No.: 241065036
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)